You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SER Conversion Disclosure
Venkatesan Jay · SEC Form 4 · Filed Jun 22, 2026
Conversion
Calculated transaction value
$217.18K
Venkatesan Jay Director
SER
Transaction date
Jun 17, 2026
Public filing date
Jun 22, 2026
Filing lag
Filed 5 days later
SER daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series A Convertible Preferred Stock on Common Stock, $0.0001 par value
- Quantity / price
- 96,525 shares @ $2.25
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001413350-26-000004
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$722.57K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Serina Therapeutics, Inc. SER | Conversion | Jun 17, 2026 | $504.34K |
| Serina Therapeutics, Inc. SER | Award | Jun 17, 2026 | $0 |
| Serina Therapeutics, Inc. SER Current | Conversion | Jun 17, 2026 | $217.18K |
| Serina Therapeutics, Inc. SER | Buy | May 22, 2026 | $1.05K |